CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
Judge dismisses federal Vioxx case
Former patient who filed suit sought dismissal, claiming lack of support and Hurricane Katrina impact on preparation.
By Aaron Smith, CNNMoney.com staff writer

NEW YORK (CNNMoney.com) - A federal judge presiding over thousands of Vioxx lawsuits against Merck on Wednesday dismissed the first case filed by a long-term patient of the painkiller.

Judge Eldon Fallon dismissed the lawsuit filed by Ellis Diaz, who had taken the arthritis painkiller Vioxx for more than 18 months, according to papers filed in the federal district court in New Orleans. Like many of the other plaintiffs in the Vioxx cases, Diaz blames Merck's (up $0.52 to $36.00, Research) former blockbuster for his non-fatal heart attack.

The dismissal was made at the request of Diaz and his lawyer Phillip Wittmann, who cited "prejudice on grounds that the plaintiff's steering committee has refused to lend support to try this matter on June 12" and the effects of Hurricane Katrina on the terms of trial preparation, according to court papers.

Merck outside counsel Philip Beck said in an e-mail to CNNMoney.com that the steering committee's "recent change of position and decision not to support Mr. Diaz's case reflects the evidence proving that Mr. Diaz's heart attack was not caused in any way by his use of Vioxx" for longer than 18 months.

To read about the ongoing Vioxx case in New Jersey, click hereTop of page

YOUR E-MAIL ALERTS
Follow the news that matters to you. Create your own alert to be notified on topics you're interested in.

Or, visit Popular Alerts for suggestions.
Manage alerts | What is this?
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.